Emmaus Life Sciences Inc. (EMMA) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:EMMA

2.77
-1.72 (-38.31%)
At close: Sep 10, 2019
2.73
-0.04 (-1.44%)
After Hours: 9/10/2019, 8:00:00 PM

EMMA Key Statistics, Chart & Performance

Key Statistics
Market Cap131.48M
Revenue(TTM)1.32M
Net Income(TTM)-9.60M
Shares47.47M
Float30.38M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-11.16
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
EMMA short term performance overview.The bars show the price performance of EMMA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

EMMA long term performance overview.The bars show the price performance of EMMA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of EMMA is 2.77 null. In the past month the price decreased by -30.75%.

Emmaus Life Sciences Inc. / EMMA Daily stock chart

EMMA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EMMA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to EMMA. Both the profitability and financial health of EMMA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EMMA Financial Highlights

Over the last trailing twelve months EMMA reported a non-GAAP Earnings per Share(EPS) of -11.16. The EPS increased by 26.19% compared to the year before.


Industry RankSector Rank
PM (TTM) -729.66%
ROA -220.74%
ROE -570.03%
Debt/Equity 0.37
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)26.19%
Revenue 1Y (TTM)923.74%

EMMA Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y50.09%
Revenue Next YearN/A

EMMA Ownership

Ownership
Inst Owners0.13%
Ins Owners46.21%
Short Float %0.01%
Short Ratio1

About EMMA

Company Profile

Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.

Company Info

Emmaus Life Sciences Inc.

21250 Hawthorne Boulevard Suite 800

Torrance CA 90503

CEO: George C. Carpenter

Phone: 310-214-0065

Emmaus Life Sciences Inc. / EMMA FAQ

What does EMMA do?

Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.


What is the stock price of Emmaus Life Sciences Inc. today?

The current stock price of EMMA is 2.77 null. The price decreased by -38.31% in the last trading session.


What is the dividend status of Emmaus Life Sciences Inc.?

EMMA does not pay a dividend.


What is the ChartMill rating of Emmaus Life Sciences Inc. stock?

EMMA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the PE ratio for EMMA stock?

Emmaus Life Sciences Inc. (EMMA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.16).


What is Emmaus Life Sciences Inc. worth?

Emmaus Life Sciences Inc. (EMMA) has a market capitalization of 131.48M null. This makes EMMA a Micro Cap stock.